SL STRATEGIES, LLC

Lobbying for BAVARIAN NORDIC · Pharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $40,000.00 income · posted Jul 22, 2025

Lobbying activity 2

Budget/Appropriations

Fiscal Year 2026 HHS Appropriations for Project BioShield Special Reserve Fund

Health Issues

Pandemic All Hazards Preparedness Act reauthorization; Global mpox response

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.